REFERENCES

A. Horváth, M.D. Lemoine, A. Löser, I. Mannhardt, F. Flenner, A.U. Uzun, C. Neuber, K. Breckwoldt, A. Hansen, E. Girdauskas, H. Reichenspurner, S. Willems, N. Jost, E. Wettwer, T. Eschenhagen, T. Christ, Low Resting Membrane Potential and Low Inward Rectifier Potassium Currents Are Not Inherent Features of hiPSC-Derived Cardiomyocytes., Stem Cell Reports. (2018). doi:10.1016/j.stemcr.2018.01.012.

L. Sala, B.J. van Meer, L.G.J. Tertoolen, J. Bakkers, M. Bellin, R.P. Davis, C. Denning, M.A.E. Dieben, T. Eschenhagen, E. Giacomelli, C. Grandela, A. Hansen, E.R. Holman, M.R.M. Jongbloed, S.M. Kamel, C.D. Koopman, Q. Lachaud, I. Mannhardt, M.P.H. Mol, D. Mosqueira, V. V Orlova, R. Passier, M.C. Ribeiro, U. Saleem, G.L. Smith, F.L. Burton, C.L. Mummery, MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo., Circ. Res. 122 (2018) e5–e16. doi:10.1161/CIRCRESAHA.117.312067.

M.D. Lemoine, I. Mannhardt, K. Breckwoldt, M. Prondzynski, H. Reichenspurner, S. Willems, A. Hansen, T. Eschenha-, Human iPSC-derived cardiomyocytes cultured in 3D engi- neered heart tissue show physiological upstroke velocity and sodium current density, (2017) 1–11. doi:10.1038/s41598-017-05600-w.

I. Mannhardt, A. Eder, B. Dumotier, M. Prondzynski, E. Krämer, M. Traebert, K.-D. Söhren, F. Flenner, K. Stathopoulou, M.D. Lemoine, L. Carrier, T. Christ, T. Eschenhagen, A. Hansen, Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae., Toxicol. Sci. 158 (2017) 164–175. doi:10.1093/toxsci/kfx081.

K. Breckwoldt, D. Letuffe-Brenière, I. Mannhardt, T. Schulze, B. Ulmer, T. Werner, A. Benzin, B. Klampe, M.C. Reinsch, S. Laufer, A. Shibamiya, M. Prondzynski, G. Mearini, D. Schade, S. Fuchs, C. Neuber, E. Krämer, U. Saleem, M.L. Schulze, M.L. Rodriguez, T. Eschenhagen, A. Hansen, Differentiation of cardiomyocytes and generation of human engineered heart tissue, Nat. Protoc. 12 (2017) 1177–1197. doi:10.1038/nprot.2017.033.

F. Weinberger, I. Mannhardt, T. Eschenhagen, Engineering Cardiac Muscle Tissue, Circ. Res. 120 (2017) 1487–1500. doi:10.1161/CIRCRESAHA.117.310738.

I. Mannhardt, U. Saleem, A. Benzin, T. Schulze, B. Klampe, T. Eschenhagen, A. Hansen, Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening, J. Vis. Exp. (2017) e55461–e55461. doi:10.3791/55461.

T. Ziegler, R. Hinkel, A. Stöhr, T. Eschenhagen, K.-L. Laugwitz, F. le Noble, R. David, A. Hansen, C. Kupatt, Thymosin β 4 Improves Differentiation and Vascularization of EHTs, Stem Cells Int. 2017 (2017) 1–10. doi:10.1155/2017/6848271.

D. Biermann, A. Eder, F. Arndt, H. Seoudy, H. Reichenspurner, T. Mir, A. Riso, R. Kozlik-Feldmann, K. Peldschus, M.G. Kaul, T. Schuler, S. Krasemann, A. Hansen, T. Eschenhagen, J.S. Sachweh, Towards a Tissue-Engineered Contractile Fontan-Conduit: The Fate of Cardiac Myocytes in the Subpulmonary Circulation, PLoS One. 11 (2016) e0166963. doi:10.1371/journal.pone.0166963.

F. Weinberger, K. Breckwoldt, S. Pecha, A. Kelly, B. Geertz, J. Starbatty, T. Yorgan, K.K.-H. Cheng, K. Lessmann, T. Stolen, M. Scherrer-Crosbie, G. Smith, H. Reichenspurner, A. Hansen, T. Eschenhagen, Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells, Sci. Transl. Med. 8 (2016) 363ra148 LP-363ra148. doi:10.1126/scitranslmed.aaf8781.

A.U. Uzun, I. Mannhardt, K. Breckwoldt, A. Horváth, S.S. Johannsen, A. Hansen, T. Eschenhagen, T. Christ, Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions., Front. Pharmacol. 7 (2016) 300. doi:10.3389/fphar.2016.00300.

F. Jacob, A.Y. Yonis, F. Cuello, P. Luther, T. Schulze, A. Eder, T. Streichert, I. Mannhardt, M.N. Hirt, S. Schaaf, J. Stenzig, T. Force, T. Eschenhagen, A. Hansen, Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue, PLoS One. 11 (2016) e0145937. doi:10.1371/journal.pone.0145937.

I. Mannhardt, K. Breckwoldt, D. Letuffe-Brenière, S. Schaaf, H. Schulz, C. Neuber, A. Benzin, T. Werner, A. Eder, T. Schulze, B. Klampe, T. Christ, M.N. Hirt, N. Huebner, A. Moretti, T. Eschenhagen, A. Hansen, Human Engineered Heart Tissue: Analysis of Contractile Force, Stem Cell Reports. 7 (2016) 29–42. doi:10.1016/j.stemcr.2016.04.011.

A. Eder, I. Vollert, A. Hansen, T. Eschenhagen, Human engineered heart tissue as a model system for drug testing, Adv. Drug Deliv. Rev. (2015). doi:10.1016/j.addr.2015.05.010.

A. Stoehr, M.N. Hirt, A. Hansen, M. Seiffert, L. Conradi, J. Uebeler, F.P. Limbourg, T. Eschenhagen, Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue., Tissue Eng. Part A. 22 (2016) 326–35. doi:10.1089/ten.TEA.2015.0242.

J. Fiedler, K. Breckwoldt, C.W. Remmele, D. Hartmann, M. Dittrich, A. Pfanne, A. Just, K. Xiao, M. Kunz, T. Müller, A. Hansen, R. Geffers, T. Dandekar, T. Eschenhagen, T. Thum, Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization., J. Am. Coll. Cardiol. 66 (2015) 2005–15. doi:10.1016/j.jacc.2015.07.081.

A. Görbe, A. Eder, Z. V Varga, J. Pálóczi, A. Hansen, P. Ferdinandy, T. Eschenhagen, Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue., PLoS One. 10 (2015) e0132186. doi:10.1371/journal.pone.0132186.

L. Conradi, S. Schmidt, E. Neofytou, T. Deuse, L. Peters, A. Eder, X. Hua, A. Hansen, R.C. Robbins, R.E. Beygui, H. Reichenspurner, T. Eschenhagen, S. Schrepfer, Immunobiology of fibrin-based engineered heart tissue., Stem Cells Transl. Med. 4 (2015) 625–31. doi:10.5966/sctm.2013-0202.

M.N. Hirt, T. Werner, D. Indenbirken, M. Alawi, P. Demin, A. Kunze, J. Stenzig, J. Starbatty, A. Hansen, J. Fiedler, T. Thum, T. Eschenhagen, Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology, J. Mol. Cell. Cardiol. 81 (2015) 1–9. doi:10.1016/j.yjmcc.2015.01.008.

J. Fiedler, A. Stöhr, S.K. Gupta, D. Hartmann, A. Holzmann, A. Just, A. Hansen, D. Hilfiker-Kleiner, T. Eschenhagen, T. Thum, Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization., Antioxid. Redox Signal. 21 (2014) 1167–76. doi:10.1089/ars.2013.5418.

M.N. Hirt, J. Boeddinghaus, A. Mitchell, S. Schaaf, C. Börnchen, C. Müller, H. Schulz, N. Hubner, J. Stenzig, A. Stoehr, C. Neuber, A. Eder, P.K. Luther, A. Hansen, T. Eschenhagen, Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation., J. Mol. Cell. Cardiol. 74C (2014) 151–161. doi:10.1016/j.yjmcc.2014.05.009.

A. Stoehr, C. Neuber, C. Baldauf, I. Vollert, F.W. Friedrich, F. Flenner, L. Carrier, A. Eder, S. Schaaf, M.N. Hirt, B. Aksehirlioglu, C.W. Tong, A. Moretti, T. Eschenhagen, A. Hansen, Automated analysis of contractile force and Ca2+ transients in engineered heart tissue., Am. J. Physiol. Heart Circ. Physiol. 306 (2014) H1353-63. doi:10.1152/ajpheart.00705.2013.

I. Vollert, M. Seiffert, J. Bachmair, M. Sander, A. Eder, L. Conradi, A. Vogelsang, T. Schulze, J. Uebeler, W. Holnthoner, H. Redl, H. Reichenspurner, A. Hansen, T. Eschenhagen, In vitro perfusion of engineered heart tissue through endothelialized channels., Tissue Eng. Part A. 20 (2014) 854–63. doi:10.1089/ten.TEA.2013.0214.

M.N. Hirt, A. Hansen, T. Eschenhagen, Cardiac tissue engineering - state of the art, Circ. Res. 114 (2013) 354–67. doi:10.1161/CIRCRESAHA.114.300522.

A. Eder, A. Hansen, J. Uebeler, T. Schulze, C. Neuber, S. Schaaf, L. Yuan, T. Christ, M. a. Vos, T. Eschenhagen, Effects of proarrhythmic drugs on relaxation time and beating pattern in rat engineered heart tissue, Basic Res. Cardiol. 109 (2014) 436. doi:10.1007/s00395-014-0436-7.

S. Schaaf, A. Eder, I. Vollert, A. Stöhr, A. Hansen, T. Eschenhagen, A. St??hr, A. Hansen, T. Eschenhagen, Generation of Strip-Format Fibrin-Based Engineered Heart Tissue (EHT)., in: M. Radisic, L.D. Black III (Eds.), Methods Mol. Biol., Humana Press, 2014: pp. 121–9. doi:10.1007/978-1-4939-1047-2_11.

A. Stöhr, F.W. Friedrich, F. Flenner, B. Geertz, A. Eder, S. Schaaf, M.N. Hirt, J. Uebeler, S. Schlossarek, L. Carrier, A. Hansen, T. Eschenhagen, Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice., J. Mol. Cell. Cardiol. 63 (2013) 189–98. doi:10.1016/j.yjmcc.2013.07.011.

C. Crocini, T. Arimura, S. Reischmann, A. Eder, I. Braren, A. Hansen, T. Eschenhagen, A. Kimura, L. Carrier, Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue., Basic Res. Cardiol. 108 (2013) 349. doi:10.1007/s00395-013-0349-x.

M.N. Hirt, N.A. Sörensen, L.M. Bartholdt, J. Boeddinghaus, S. Schaaf, A. Eder, I. Vollert, A. Stöhr, T. Schulze, A. Witten, M. Stoll, A. Hansen, T. Eschenhagen, Increased afterload induces pathological cardiac hypertrophy: a new in vitro model., Basic Res. Cardiol. 107 (2012) 307–323. doi:10.1007/s00395-012-0307-z.

T. Eschenhagen, A. Eder, I. Vollert, A. Hansen, Physiological aspects of cardiac tissue engineering., Am. J. Physiol. Heart Circ. Physiol. 303 (2012) H133-43. doi:10.1152/ajpheart.00007.2012.

F.W. Friedrich, B.R. Wilding, S. Reischmann, C. Crocini, P. Lang, P. Charron, O.J. Müller, M.J. McGrath, I. Vollert, A. Hansen, W.A. Linke, C. Hengstenberg, G. Bonne, S. Morner, T. Wichter, H. Madeira, E. Arbustini, T. Eschenhagen, C.A. Mitchell, R. Isnard, L. Carrier, Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy., Hum. Mol. Genet. 21 (2012) 3237–54. doi:10.1093/hmg/dds157.

S. Chiron, C. Tomczak, A. Duperray, J. Lainé, G. Bonne, A. Eder, A. Hansen, T. Eschenhagen, C. Verdier, C. Coirault, Complex interactions between human myoblasts and the surrounding 3D fibrin-based matrix., PLoS One. 7 (2012) e36173. doi:10.1371/journal.pone.0036173.

L. Conradi, C. Pahrmann, S. Schmidt, T. Deuse, A. Hansen, A. Eder, H. Reichenspurner, R.C. Robbins, T. Eschenhagen, S. Schrepfer, Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT)., J. Vis. Exp. (2011). doi:10.3791/2605.

S. Schaaf, A. Shibamiya, M. Mewe, A. Eder, A. Stöhr, M.N. Hirt, T. Rau, W.-H. Zimmermann, L. Conradi, T. Eschenhagen, A. Hansen, Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology, PLoS One. 6 (2011) e26397. doi:10.1371/journal.pone.0026397.

A. Hansen, A. Eder, M. Bönstrup, M. Flato, M. Mewe, S. Schaaf, B. Aksehirlioglu, A.P. Schwoerer, J. Uebeler, T. Eschenhagen, A. Schwörer, J. Uebeler, T. Eschenhagen, A.P. Schwoerer, Development of a drug screening platform based on engineered heart tissue., Circ. Res. 107 (2010) 35–44. doi:10.1161/CIRCRESAHA.109.211458.